OrbiMed’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Hold |
1,923,855
| – | – | 0.36% | 49 |
|
|
2025
Q1 | $14.6M | Sell |
1,923,855
-18,700
| -1% | -$142K | 0.35% | 52 |
|
|
2024
Q4 | $23.7M | Buy |
1,942,555
+872,500
| +82% | +$10.6M | 0.49% | 46 |
|
|
2024
Q3 | $17.9M | Sell |
1,070,055
-77,600
| -7% | -$1.3M | 0.33% | 68 |
|
|
2024
Q2 | $20M | Buy |
1,147,655
+630,049
| +122% | +$11M | 0.4% | 61 |
|
|
2024
Q1 | $8.82M | Sell |
517,606
-27,242
| -5% | -$464K | 0.16% | 83 |
|
|
2023
Q4 | $5.55M | Hold |
544,848
| – | – | 0.11% | 88 |
|
|
2023
Q3 | $4.93M | Hold |
544,848
| – | – | 0.1% | 96 |
|
|
2023
Q2 | $5.86M | Sell |
544,848
-60,539
| -10% | -$651K | 0.11% | 95 |
|
|
2023
Q1 | $6.19M | Sell |
605,387
-31,900
| -5% | -$326K | 0.12% | 96 |
|
|
2022
Q4 | $6.72M | Hold |
637,287
| – | – | 0.13% | 84 |
|
|
2022
Q3 | $8.17K | Sell |
637,287
-33,500
| -5% | -$429 | 0.15% | 90 |
|
|
2022
Q2 | $8.6K | Hold |
670,787
| – | – | 0.16% | 97 |
|
|
2022
Q1 | $7.02M | Sell |
670,787
-134,254
| -17% | -$1.41M | 0.11% | 110 |
|
|
2021
Q4 | $12.4M | Sell |
805,041
-341,104
| -30% | -$5.26M | 0.16% | 109 |
|
|
2021
Q3 | $25.9M | Hold |
1,146,145
| – | – | 0.28% | 85 |
|
|
2021
Q2 | $29.5M | Hold |
1,146,145
| – | – | 0.3% | 77 |
|
|
2021
Q1 | $47.8M | Buy |
+1,146,145
| New | +$47.8M | 0.45% | 64 |
|